Novabay Pharmaceuticals (NBY)
0.5299 +0.0399 (+8.14%) 04/11/25 [NYSE Arca]
0.5003 x 1,300 0.6281 x 100
Realtime by (Cboe BZX)
0.5003 x 1,300 0.6281 x 100
Realtime 0.5300 +0.0001 (-) 19:03 ET
for Fri, Apr 11th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,223 | -9,640 | -10,608 | -5,824 | -11,039 |
| Depreciation Amortization | 40 | 51 | 7,220 | 119 | 51 |
| Accounts receivable | 291 | 846 | -305 | 452 | -317 |
| Other Working Capital | -595 | -433 | 533 | -38 | 210 |
| Other Operating Activity | 2,304 | 4,915 | -3,494 | -3,901 | 6,374 |
| Operating Cash Flow | $-5,183 | $-4,261 | $-6,654 | $-9,192 | $-4,721 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -19 | -112 | -52 | -26 |
| Net Acquisitions | 1,070 | N/A | N/A | -11,993 | N/A |
| Investing Cash Flow | $1,064 | $-19 | $-112 | $-12,045 | $-26 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 500 | 3,000 | N/A | N/A | N/A |
| Debt Repayment | -1,990 | -1,474 | N/A | N/A | -1,563 |
| Common Stock Issued | 3,105 | 565 | 1,703 | 1,776 | 12,325 |
| Other Financing Activity | -115 | -181 | 2,930 | 15,013 | -1,000 |
| Financing Cash Flow | $1,500 | $1,910 | $4,633 | $16,789 | $9,762 |
| Beginning Cash Position | 3,606 | 5,846 | 7,979 | 12,427 | 7,412 |
| End Cash Position | 907 | 3,400 | 5,846 | 7,979 | 12,427 |
| Net Cash Flow | $-2,699 | $-2,446 | $-2,133 | $-4,448 | $5,015 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,183 | -4,261 | -6,654 | -9,192 | -4,721 |
| Capital Expenditure | -6 | -19 | -112 | -52 | -26 |
| Free Cash Flow | -5,189 | -4,280 | -6,766 | -9,244 | -4,747 |